FDA CLEARS FIRST PATIENT-SPECIFIC SPINAL ROD (Orthopedics This Week)
The French-based Medicrea Group says it has received FDA 510(k) clearance for its UNiD spinal device, which according to the company, is the world’s first patient-specific spinal osteosynthesis rod to treat degenerative spine conditions including scoliosis.
The technology was introduced at the 2014 North American Spine Society (NASS) Annual Meeting on November 12, 2014 in San Francisco, California. The first U.S. patient underwent surgery to have personalized UNiD rods implanted on November 10, 2014 in New York. The surgery w...
The Orthopedics Industry 
